Sarcopoterium spinosum extract as an antidiabetic agent: In vitro and in vivo study

Journal of Ethnopharmacology

Volumn 129, Issue 1, 2010, Pages 10-17

  Smirin, Polina ^a,b   Taler, Dvir ^b,c   Abitbol, Guila ^a,b   Brutman Barazani, Tamar ^b   Kerem, Zohar ^d   Sampson, Sanford R ^b   Rosenzweig, Tovit ^a  

^a ARIEL UNIVERSITY   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c R and D Center Samaria and Jordan Rift   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Cathechin; Diabetes; KK Ay mice; Medicinal plant; Sarcopoterium spinosum (L.) sp.

Indexed keywords

CATECHIN; EPICATECHIN; FATTY ACID; GLUCOSE; GLYCOGEN; GLYCOGEN SYNTHASE KINASE 3BETA; HERBACEOUS AGENT; INSULIN; SARCOPOTERIUM SPINOSUM EXTRACT; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; FORSKOLIN; PLANT EXTRACT;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DETERMINATION; DRUG EFFICACY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; FATTY ACID BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; LIPOLYSIS; LIVER CELL; MALE; MEDICINAL PLANT; MOUSE; MYOTUBE; NONHUMAN; PANCREAS ISLET BETA CELL; RAT; SARCOPOTERIUM SPINOSUM; SINGLE DRUG DOSE; 3T3 CELL LINE; ANIMAL; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DISEASE COURSE; DRUG EFFECTS; GLUCOSE TOLERANCE TEST; INBRED MOUSE STRAIN; METABOLISM; PHOSPHORYLATION; PHYTOTHERAPY; PLANT ROOT; ROSACEAE; SECRETION (PROCESS); SKELETAL MUSCLE; TRANSPORT AT THE CELLULAR LEVEL;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BIOLOGICAL TRANSPORT; CATECHIN; CELL LINE; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; DISEASE PROGRESSION; FORSKOLIN; GLUCOSE; GLUCOSE TOLERANCE TEST; GLYCOGEN; HEPATOCYTES; HYPOGLYCEMIC AGENTS; INSULIN; LIPOLYSIS; MALE; MICE; MICE, INBRED STRAINS; MUSCLE FIBERS, SKELETAL; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; ROSACEAE; COLFORSIN;

MUS; SARCOPOTERIUM SPINOSUM;

EID: 77951979256     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.02.021     Document Type: Article

References (32)

1. Ahren B. Type 2 diabetes, insulin secretion and beta-cell mass. Current Molecular Medicine 2005, 5:275-286.
2. Al-Qura'n S. Ethnopharmacological survey of wild medicinal plants in Showbak, Jordan. Journal of Ethnopharmacology 2009, 123:45-50.
3. Ali-Shtayeh M.S., Yaniv Z., Mahajna J. Ethnobotanical survey in the Palestinian area: a classification of the healing potential of medicinal plants. Journal of Ethnopharmacology 2000, 73:221-232.
4. Bouche C., Serdy S., Kahn C.R., Goldfine A.B. The cellular fate of glucose and its relevance in type 2 diabetes. Endocrine Reviews 2004, 25:807-830.
5. Collins Q.F., Liu H.Y., Pi J., Liu Z., Quon M.J., Cao W. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase. Journal of Biological Chemistry 2007, 282:30143-30149.
6. Dafni A., Yaniv Z., Palevitch D. Ethnobotanical survey of medicinal-plants in Northern Israel. Journal of Ethnopharmacology 1984, 10:295-310.
7. Enoki T., Ohnogi H., Nagamine K., Kudo Y., Sugiyama K., Tanabe M., Kobayashi E., Sagawa H., Kato I. Antidiabetic activities of chalcones isolated from a Japanese Herb, Angelica keiskei. Journal of Agricultural and Food Chemistry 2007, 55:6013-6017.
8. Frame S., Zheleva D. Targeting glycogen synthase kinase-3 in insulin signalling. Expert Opinion on Therapeutic Targets 2006, 10:429-444.
9. Friedman J., Yaniv Z., Dafni A., Palewitch D. A preliminary classification of the healing potential of medicinal-plants, based on a rational analysis of an Ethnopharmacological Field Survey among Bedouins in the Negev Desert, Israel. Journal of Ethnopharmacology 1986, 16:275-287.
10. Frost S.C., Lane M.D. Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. Journal of Biological Chemistry 1985, 260:2646-2652.
11. Hamdan I.I., Afifi F.U. Studies on the in vitro and in vivo hypoglycemic activities of some medicinal plants used in treatment of diabetes in Jordanian traditional medicine. Journal of Ethnopharmacology 2004, 93:117-121.
12. Henkin Z., Seligman N.G. Survival of Sarcopoterium spinosum seedlings growing on terra rossa soil. Israel Journal of Plant Sciences 2007, 55:45-51.
13. Henriksen E.J., Dokken B.B. Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Current Drug Targets 2006, 7:1435-1441.
14. Jouad H., Haloui M., Rhiouani H., El H.J., Eddouks M. Ethnobotanical survey of medicinal plants used for the treatment of diabetes, cardiac and renal diseases in the North centre region of Morocco (Fez-Boulemane). Journal of Ethnopharmacology 2001, 77:175-182.
15. Kralisch S., Klein J., Lossner U., Bluher M., Paschke R., Stumvoll M., Fasshauer M. Isoproterenol, TNFalpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes. Molecular and Cellular Endocrinology 2005, 43-49:240.
16. Large V., Peroni O., Letexier D., Ray H., Beylot M. Metabolism of lipids in human white adipocyte. Diabetes & Metabolism 2004, 30:294-309.
17. Maedler K., Donath M.Y. Beta-cells in type 2 diabetes: a loss of function and mass. Hormone Research 2004, 62:67-73.
18. Miura T., Ueda N., Yamada K., Fukushima M., Ishida T., Kaneko T., Matsuyama F., Seino Y. Antidiabetic effects of corosolic acid in KK-Ay diabetic mice. Biological & Pharmaceutical Bulletin 2006, 29:585-587.
19. Nagao T., Meguro S., Hase T., Otsuka K., Komikado M., Tokimitsu I., Yamamoto T., Yamamoto K. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity (Silver Spring) 2009, 17:310-317.
20. Nahas R., Moher M. Complementary and alternative medicine for the treatment of type 2 diabetes. Canadian Family Physician 2009, 55:591-596.
21. Nelson B.C., Sharpless K.E. Quantification of the predominant monomeric catechins in baking chocolate standard reference material by LC/APCI-MS. Journal of Agricultural and Food Chemistry 2003, 51:531-537.
22. Prabhakar P.K., Doble M. A target based therapeutic approach towards diabetes mellitus using medicinal plants. Current Diabetes Reviews 2008, 4:291-308.
23. Reher G., Reznicek G., Baumann A. Triterpenoids from Sarcopoterium spinosum and Sanguisorba minor. Planta Medica 1991, 57:506.
24. Saad B., Azaizeh H., Said O. Tradition and perspectives of Arab herbal medicine: a review. Evidence-based Complementary and Alternative Medicine 2005, 2:475-479.
25. Samad A., Shams M.S., Ullah Z., Wais M., Nazish I., Sultana Y., Aqil M. Status of herbal medicines in the treatment of diabetes: a review. Current Diabetes Review 2009, 5:102-111.
26. Shani J., Joseph B., Sulman F.G. Fluctuations in the hypoglycaemic effect of Poterium spinosum L. (Rosaceae). Archives Internationales de Pharmacodynamie et de Therapie 1970, 185:344-349.
27. Thielecke F., Boschmann M. The potential role of green tea catechins in the prevention of the metabolic syndrome-a review. Phytochemistry 2009, 70:11-24.
28. Ueda M., Nishiumi S., Nagayasu H., Fukuda I., Yoshida K., Ashida H. Epigallocatechin gallate promotes GLUT4 translocation in skeletal muscle. Biochemical and Biophysical Research Communication 2008, 377:286-290.
29. Winkelman M. Ethnobotanical treatments of diabetes in Baja California Norte. Medical Anthropology 1989, 11:255-268.
30. Wolfram S., Raederstorff D., Preller M., Wang Y., Teixeira S.R., Riegger C., Weber P. Epigallocatechin gallate supplementation alleviates diabetes in rodents. Journal of Nutrition 2006, 136:2512-2518.
31. Yaniv Z., Dafni A., Friedman J., Palevitch D. Plants used for the treatment of diabetes in Israel. Journal of Ethnopharmacology 1987, 19:145-151.
32. Yin W., Mu J., Birnbaum M.J. Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis In 3T3-L1 adipocytes. Journal of Biological Chemistry 2003, 278:43074-43080.